| Alexander P Kallas, MD | |
|
500 17th Ave, Seattle, WA 98122-5711 | |
| (206) 320-2111 | |
| (206) 320-3396 |
| Full Name | Alexander P Kallas |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 37 Years |
| Location | 500 17th Ave, Seattle, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548324577 | NPI | - | NPPES |
| 8406688 | Medicaid | WA | |
| 0189706 | Other | WA | LABOR AND INDUSTRIES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00044113 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
The immune system functions as the body's defense against pathogens and harmful substances, including cancer cells. They protect the body against potential harm. In cases of cancer, though the body tries to fight the tumor cells, they may become too aggressive for the immune system to eradicate.
"Sustainable development cannot be realized unless hunger and malnutrition are eradicated, the [Food and Agriculture Organization (FAO)] said in a policy document prepared for the Rio+20 Summit to be held in June in Rio de Janeiro," an FAO press release reports.
Cognitive behavioural therapy is a promising option for patients with schizophrenia who refuse to take antipsychotics, show the findings of a pilot randomised trial.
Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.
› Verified 1 days ago
| Entity Name | Jefferson County Public Hospital District No 2 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356492953 PECOS PAC ID: 4789593708 Enrollment ID: O20031111000542 |
News Archive
The immune system functions as the body's defense against pathogens and harmful substances, including cancer cells. They protect the body against potential harm. In cases of cancer, though the body tries to fight the tumor cells, they may become too aggressive for the immune system to eradicate.
"Sustainable development cannot be realized unless hunger and malnutrition are eradicated, the [Food and Agriculture Organization (FAO)] said in a policy document prepared for the Rio+20 Summit to be held in June in Rio de Janeiro," an FAO press release reports.
Cognitive behavioural therapy is a promising option for patients with schizophrenia who refuse to take antipsychotics, show the findings of a pilot randomised trial.
Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.
› Verified 1 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
The immune system functions as the body's defense against pathogens and harmful substances, including cancer cells. They protect the body against potential harm. In cases of cancer, though the body tries to fight the tumor cells, they may become too aggressive for the immune system to eradicate.
"Sustainable development cannot be realized unless hunger and malnutrition are eradicated, the [Food and Agriculture Organization (FAO)] said in a policy document prepared for the Rio+20 Summit to be held in June in Rio de Janeiro," an FAO press release reports.
Cognitive behavioural therapy is a promising option for patients with schizophrenia who refuse to take antipsychotics, show the findings of a pilot randomised trial.
Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexander P Kallas, MD Po Box 84026, Seattle, WA 98124-8426 Ph: (206) 320-2111 | Alexander P Kallas, MD 500 17th Ave, Seattle, WA 98122-5711 Ph: (206) 320-2111 |
News Archive
The immune system functions as the body's defense against pathogens and harmful substances, including cancer cells. They protect the body against potential harm. In cases of cancer, though the body tries to fight the tumor cells, they may become too aggressive for the immune system to eradicate.
"Sustainable development cannot be realized unless hunger and malnutrition are eradicated, the [Food and Agriculture Organization (FAO)] said in a policy document prepared for the Rio+20 Summit to be held in June in Rio de Janeiro," an FAO press release reports.
Cognitive behavioural therapy is a promising option for patients with schizophrenia who refuse to take antipsychotics, show the findings of a pilot randomised trial.
Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.
› Verified 1 days ago
Sasha Kaiser, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Kristopher Allen Hendershot, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Dr. Lauren Kristen Whiteside, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-744-8464 | |
Brenda Park, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-368-5762 Fax: 814-537-5677 | |
Rhadika Mccormick Souza, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 925 Seneca St, Seattle, WA 98101 Phone: 206-583-6433 Fax: 206-583-6583 | |
Eleanor Ganz, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-598-4955 | |
Dr. Gary H. Somers, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-368-1765 |